Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
226.5 SEK | -0.44% | +2.72% | +6.84% |
Apr. 25 | Transcript : CellaVision AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | CellaVision AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Sales per Business
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Instruments
56.2
%
| 357 | 55.9 % | 380 | 56.2 % | +6.43% |
Software and Other
24.9
%
| 182 | 28.5 % | 169 | 24.9 % | -7.24% |
Reagents
18.9
%
| 100 | 15.6 % | 128 | 18.9 % | +28.20% |
Sales per region
SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
41.4
%
| - | - | 280 | 41.4 % | - |
France
20.6
%
| - | - | 140 | 20.6 % | - |
APAC
12.8
%
| 79 | 12.3 % | 87 | 12.8 % | +9.96% |
EMEA
11.3
%
| 280 | 43.8 % | 77 | 11.3 % | -72.56% |
Germany
9.0
%
| - | - | 61 | 9.0 % | - |
Americas
4.9
%
| 280 | 43.8 % | 33 | 4.9 % | -88.27% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Simon Ostergaard
CEO | Chief Executive Officer | 53 | 21-03-20 |
Magnus Blixt
DFI | Director of Finance/CFO | 58 | 13-05-01 |
Kent Stråhlen
BRD | Director/Board Member | 56 | 00-08-31 |
Adele Horn
IRC | Investor Relations Contact | - | - |
Jeppe Brandstrup
PRN | Corporate Officer/Principal | 40 | 15-12-31 |
Peter Wilson
SAM | Sales & Marketing | 57 | 99-12-31 |
Urban Strindlöv
SAM | Sales & Marketing | 60 | 21-12-31 |
Adam Morell
PRN | Corporate Officer/Principal | 48 | 05-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Lotta Jarleryd
BRD | Director/Board Member | 58 | 22-05-10 |
Mikael Worning
CHM | Chairman | 62 | 20-04-22 |
Stefan Wolf
BRD | Director/Board Member | 60 | 18-05-03 |
Kent Stråhlen
BRD | Director/Board Member | 56 | 00-08-31 |
Director/Board Member | 52 | 22-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,851,547 | 14,779,149 ( 61.96 %) | 0 | 61.96 % |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.84% | 500M | |
-42.33% | 2.84B | |
+17.00% | 1.85B | |
-0.51% | 1.66B | |
+27.15% | 1.26B | |
-13.90% | 989M | |
-21.76% | 896M | |
-2.72% | 757M | |
-23.95% | 633M | |
-.--% | 306M |
- Stock Market
- Equities
- CEVI Stock
- Company CellaVision AB